Related Experiment Video
Updated: Jun 10, 2025
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.2K
Interplay between cannabinoids and the neuroimmune system in migraine
Erik Zorrilla1, Adriana Della Pietra1, Andrew F Russo2,3,4
1Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA, 52242, USA.
The Journal of Headache and Pain
|October 15, 2024
Summary
Cannabinoids may offer new migraine treatments by targeting immune cells involved in pain. Research suggests cannabinoids could enhance current therapies by modulating immune cell activity, though more studies are needed.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Migraine is a complex neurological disorder significantly impacting quality of life.
- Current treatments targeting calcitonin gene-related peptide (CGRP) show promise but are insufficient.
- CGRP release from trigeminal nerves contributes to migraine pathophysiology, potentially involving immune cells.
Purpose of the Study:
- To review the potential of targeting immune cells with cannabinoids for novel migraine therapeutics.
- To explore the roles of endogenous, plant-derived, and synthetic cannabinoids in modulating immune cell activity relevant to migraine.
Main Methods:
- Review of literature on cannabinoid interactions with specific immune cells (macrophages, monocytes, mast cells, dendritic cells, B cells, T cells).
- Examination of immune cell expression of cannabinoid and CGRP receptors.
- Analysis of preclinical and clinical studies on cannabinoid-based migraine therapies.
Main Results:
- Immune cells express receptors for both cannabinoids and CGRP, suggesting potential therapeutic synergy.
- A preclinical study showed a cannabinoid analog reduced mast cell degranulation in a migraine model.
- Limited but encouraging clinical trial data exist for cannabinoid therapies in migraine.
Conclusions:
- Cannabinoid modulation of immune cells presents a promising, innovative therapeutic avenue for migraine.
- Significant knowledge gaps remain regarding cannabinoid-immune cell interactions in migraine.
- Further research is crucial for developing targeted and effective cannabinoid-based migraine treatments.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
203
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
203
01:26Neurochemical Transmission: Sites of Drug Action
2.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.1K
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
166
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
166
01:25Analgesia and Pain Management
540
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
540
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
151
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
151
01:31Neurotransmitters
819
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
819